Tag: Pharmaceutical Economics and Policy
Goma medicine retailers share common professional features
How pharmacy retailers function as professionals in an underregulated African health system
Industry payments were linked to more brand-name MS prescribing
How drug company payments to doctors influence multiple sclerosis prescription choices
Most favored nation drug pricing may lower industry research revenue
International drug pricing policy and pharmaceutical innovation capacity
Zuranolone was approved for postpartum depression, not major depressive disorder
How expedited drug approval processes may compromise regulatory safety standards
Drug shortages create risks in obstetric care
Strategies to prepare obstetric care systems for increasing medication shortages
